{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:05:16Z","timestamp":1753891516115,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, can have a wide range of clinical manifestations, ranging from asymptomatic disease to potentially life-threatening complications. Convalescent plasma therapy has been proposed as an effective alternative for the treatment of severe cases. The aim of this study was to follow a two-time renal transplant patient with severe COVID-19 treated with convalescent plasma over time from an immunologic and virologic perspective. A 42-year-old female patient, who was a two-time kidney transplant recipient, was hospitalized with COVID-19. Due to worsening respiratory symptoms, she was admitted to the intensive care unit, where she received two doses of convalescent plasma. We analyzed the dynamics of viral load in nasopharyngeal swab, saliva, and tracheal aspirate samples, before and after convalescent plasma transfusion. The levels of pro-inflammatory cytokines and antibody titers were also measured in serum samples. A significant decrease in viral load was observed after treatment in the saliva and nasopharyngeal swab samples, and a slight decrease was observed in tracheal aspirate samples. In addition, we found evidence of an increase in antibody titers after transfusion, accompanied by a decrease in the levels of several cytokines responsible for cytokine storm.<\/jats:p>","DOI":"10.3389\/fneph.2023.1132763","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T14:01:33Z","timestamp":1687615293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of viral load evolution and immune response"],"prefix":"10.3389","volume":"3","author":[{"given":"Fabian","family":"Aldunate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia","family":"Rammauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellen","family":"Daghero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Arce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ferla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianoel","family":"Pereira-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorio","family":"Iraola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Pritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Tenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela","family":"Bollati-Fogol\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Nin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Moratorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"B1","unstructured":"Coronavirus (COVID-19) dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data2022"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/emph\/eoab005","article-title":"Cytokine storms, evolution and COVID-19","volume":"9","author":"Alcock","year":"2021","journal-title":"Evol Med Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe covid-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01708","article-title":"Article 1708 (2020) cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Clerici","year":"2019","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9927","DOI":"10.1038\/s41598-021-89444-5","article-title":"Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease","volume":"11","author":"AlQahtani","year":"2021","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19","volume":"324","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031304","article-title":"A randomized trial of convalescent plasma in covid-19 severe pneumonia","volume":"384","author":"Simonovich","year":"2021","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9535","article-title":"Convalescent plasma therapy and its effects on COVID-19 patient outcomes: a systematic review of current literature","volume":"12","author":"Bakhtawar","year":"2020","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40121-021-00514-7","article-title":"Early transfusion of convalescent plasma improves the clinical outcome in severe SARS-CoV2 infection","volume":"11","author":"Fodor","year":"2022","journal-title":"Infect Dis Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.684151","article-title":"Convalescent plasma therapy for COVID-19: a graphical mosaic of the worldwide evidence","volume":"8","author":"Klassen","year":"2021","journal-title":"Front Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01488-2","article-title":"Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial","volume":"27","author":"B\u00e9gin","year":"2021","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.2021.18178","article-title":"Effect of convalescent plasma on organ support\u2013free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"326","author":"Abdelhady","year":"2021","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2021.12339","article-title":"Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses","volume":"326","author":"Benotmane","year":"2021","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/14760584.2021.1932475","article-title":"Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations","volume":"21","author":"Focosi","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0275","article-title":"Case report: viral shedding for 60 days in a woman with COVID-19","volume":"102","author":"Li","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15891","article-title":"COVID-19 in kidney transplant recipients","volume":"20","author":"Gandolfini","year":"2020","journal-title":"Am J Transplant"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15874","article-title":"Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation","volume":"20","author":"Guillen","year":"2020","journal-title":"Am J Transplant"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13296","article-title":"Case report: a kidney transplant patient with mild COVID-19","volume":"22","author":"Arpali","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003962","article-title":"Efficacy of convalescent plasma to treat mild to moderate COVID-19 in kidney transplant patients: a propensity score matching analysis","volume":"106","author":"Cristelli","year":"2022","journal-title":"Transplantation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"106204","DOI":"10.1016\/j.ijsu.2021.106204","article-title":"Convalescent plasma therapy against the emerging SARS-CoV-2 variants: delineation of the potentialities and risks","volume":"97","author":"Dhawan","year":"2022","journal-title":"Int J Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01678-y","article-title":"An infectious SARS-CoV-2 B.1.1.529 omicron virus escapes neutralization by therapeutic monoclonal antibodies","volume":"28","author":"VanBlargan","year":"2022","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41581-022-00642-4","article-title":"Therapeutic advances in COVID-19","volume":"19","author":"Murakami","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15452","article-title":"Therapeutic strategies to fight COVID-19: which is the status artis","volume":"179","author":"Scavone","year":"2022","journal-title":"Br J Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-023-01769-3","article-title":"Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations","author":"Gangavarapu","year":"2023","journal-title":"Nature Methods"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.3201\/eid2711.211198","article-title":"Real-time genomic surveillance for SARS-CoV-2 variants of concern, Uruguay","volume":"27","author":"Rego","year":"2021","journal-title":"Emerg Infect Dis J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1860.e7","DOI":"10.1016\/j.cmi.2021.07.030","article-title":"Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients","volume":"27","author":"Slezak","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100713","DOI":"10.1016\/j.nmni.2020.100713","article-title":"Laboratory diagnosis of SARS-CoV-2: available approaches and limitations","volume":"36","author":"Abduljalil","year":"2020","journal-title":"New Microbes New Infect"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00297-20","article-title":"Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19","volume":"58","author":"Winichakoon","year":"2020","journal-title":"J Clin Microbiol"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2023.1132763\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T14:01:39Z","timestamp":1687615299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2023.1132763\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":30,"alternative-id":["10.3389\/fneph.2023.1132763"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2023.1132763","relation":{},"ISSN":["2813-0626"],"issn-type":[{"type":"electronic","value":"2813-0626"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"article-number":"1132763"}}